1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients

Michael B. Lauridsen, Henning Bliddal, Robin Christensen, Bente Danneskiold-Samsøe, Robert (Rob) Bennett, Hector Keun, John C. Lindon, Jeremy K. Nicholson, Mikkel H. Dorff, Jerzy W. Jaroszewski, Steen H. Hansen, Claus Cornett

    Research output: Contribution to journalArticle

    60 Citations (Scopus)

    Abstract

    1H NMR spectroscopy-based metabolic phenotyping was used to identify biomarkers in the plasma of patients with rheumatoid arthritis (RA). Forty-seven patients with RA (23 with active disease at baseline and 24 in remission) and 51 healthy subjects were evaluated during a one-year follow-up with assessments of disease activity (DAS-28) and 1H NMR spectroscopy of plasma samples. Discriminant analysis provided evidence that the metabolic profiles predicted disease severity. Cholesterol, lactate, acetylated glycoprotein, and lipid signatures were found to be candidate biomarkers for disease severity. The results also supported the link between RA and coronary artery disease. Repeated assessment using mixed linear models showed that the predictors obtained from metabolic profiles of plasma at baseline from patients with active RA were significantly different from those of patients in remission (P = 0.0007). However, after 31 days of optimized therapy, the two patient groups were not significantly different (P = 0.91). The metabolic profiles of both groups of RA patients were different from the healthy subjects. 1H NMR-based metabolic phenotyping of plasma samples in patients with RA is well suited for discovery of biomarkers and may be a potential approach for disease monitoring and personalized medication for RA therapy.

    Original languageEnglish (US)
    Pages (from-to)4545-4553
    Number of pages9
    JournalJournal of Proteome Research
    Volume9
    Issue number9
    DOIs
    StatePublished - Sep 3 2010

    Fingerprint

    Nuclear magnetic resonance spectroscopy
    Rheumatoid Arthritis
    Cohort Studies
    Magnetic Resonance Spectroscopy
    Biomarkers
    Metabolome
    Plasmas
    amsonic acid
    Healthy Volunteers
    Discriminant analysis
    Discriminant Analysis
    Proton Magnetic Resonance Spectroscopy
    Lactic Acid
    Glycoproteins
    Cholesterol
    Coronary Artery Disease
    Nuclear magnetic resonance
    Linear Models
    Lipids
    Monitoring

    Keywords

    • chemometrics
    • disease monitoring
    • metabonomics
    • NMR
    • personalized medicine
    • phenotyping
    • rheumatoid arthritis

    ASJC Scopus subject areas

    • Biochemistry
    • Chemistry(all)

    Cite this

    Lauridsen, M. B., Bliddal, H., Christensen, R., Danneskiold-Samsøe, B., Bennett, R. R., Keun, H., ... Cornett, C. (2010). 1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients. Journal of Proteome Research, 9(9), 4545-4553. https://doi.org/10.1021/pr1002774

    1H NMR spectroscopy-based interventional metabolic phenotyping : A cohort study of rheumatoid arthritis patients. / Lauridsen, Michael B.; Bliddal, Henning; Christensen, Robin; Danneskiold-Samsøe, Bente; Bennett, Robert (Rob); Keun, Hector; Lindon, John C.; Nicholson, Jeremy K.; Dorff, Mikkel H.; Jaroszewski, Jerzy W.; Hansen, Steen H.; Cornett, Claus.

    In: Journal of Proteome Research, Vol. 9, No. 9, 03.09.2010, p. 4545-4553.

    Research output: Contribution to journalArticle

    Lauridsen, MB, Bliddal, H, Christensen, R, Danneskiold-Samsøe, B, Bennett, RR, Keun, H, Lindon, JC, Nicholson, JK, Dorff, MH, Jaroszewski, JW, Hansen, SH & Cornett, C 2010, '1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients', Journal of Proteome Research, vol. 9, no. 9, pp. 4545-4553. https://doi.org/10.1021/pr1002774
    Lauridsen MB, Bliddal H, Christensen R, Danneskiold-Samsøe B, Bennett RR, Keun H et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients. Journal of Proteome Research. 2010 Sep 3;9(9):4545-4553. https://doi.org/10.1021/pr1002774
    Lauridsen, Michael B. ; Bliddal, Henning ; Christensen, Robin ; Danneskiold-Samsøe, Bente ; Bennett, Robert (Rob) ; Keun, Hector ; Lindon, John C. ; Nicholson, Jeremy K. ; Dorff, Mikkel H. ; Jaroszewski, Jerzy W. ; Hansen, Steen H. ; Cornett, Claus. / 1H NMR spectroscopy-based interventional metabolic phenotyping : A cohort study of rheumatoid arthritis patients. In: Journal of Proteome Research. 2010 ; Vol. 9, No. 9. pp. 4545-4553.
    @article{676ff3ef8c6b4b39a946878adedb48d0,
    title = "1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients",
    abstract = "1H NMR spectroscopy-based metabolic phenotyping was used to identify biomarkers in the plasma of patients with rheumatoid arthritis (RA). Forty-seven patients with RA (23 with active disease at baseline and 24 in remission) and 51 healthy subjects were evaluated during a one-year follow-up with assessments of disease activity (DAS-28) and 1H NMR spectroscopy of plasma samples. Discriminant analysis provided evidence that the metabolic profiles predicted disease severity. Cholesterol, lactate, acetylated glycoprotein, and lipid signatures were found to be candidate biomarkers for disease severity. The results also supported the link between RA and coronary artery disease. Repeated assessment using mixed linear models showed that the predictors obtained from metabolic profiles of plasma at baseline from patients with active RA were significantly different from those of patients in remission (P = 0.0007). However, after 31 days of optimized therapy, the two patient groups were not significantly different (P = 0.91). The metabolic profiles of both groups of RA patients were different from the healthy subjects. 1H NMR-based metabolic phenotyping of plasma samples in patients with RA is well suited for discovery of biomarkers and may be a potential approach for disease monitoring and personalized medication for RA therapy.",
    keywords = "chemometrics, disease monitoring, metabonomics, NMR, personalized medicine, phenotyping, rheumatoid arthritis",
    author = "Lauridsen, {Michael B.} and Henning Bliddal and Robin Christensen and Bente Danneskiold-Sams{\o}e and Bennett, {Robert (Rob)} and Hector Keun and Lindon, {John C.} and Nicholson, {Jeremy K.} and Dorff, {Mikkel H.} and Jaroszewski, {Jerzy W.} and Hansen, {Steen H.} and Claus Cornett",
    year = "2010",
    month = "9",
    day = "3",
    doi = "10.1021/pr1002774",
    language = "English (US)",
    volume = "9",
    pages = "4545--4553",
    journal = "Journal of Proteome Research",
    issn = "1535-3893",
    publisher = "American Chemical Society",
    number = "9",

    }

    TY - JOUR

    T1 - 1H NMR spectroscopy-based interventional metabolic phenotyping

    T2 - A cohort study of rheumatoid arthritis patients

    AU - Lauridsen, Michael B.

    AU - Bliddal, Henning

    AU - Christensen, Robin

    AU - Danneskiold-Samsøe, Bente

    AU - Bennett, Robert (Rob)

    AU - Keun, Hector

    AU - Lindon, John C.

    AU - Nicholson, Jeremy K.

    AU - Dorff, Mikkel H.

    AU - Jaroszewski, Jerzy W.

    AU - Hansen, Steen H.

    AU - Cornett, Claus

    PY - 2010/9/3

    Y1 - 2010/9/3

    N2 - 1H NMR spectroscopy-based metabolic phenotyping was used to identify biomarkers in the plasma of patients with rheumatoid arthritis (RA). Forty-seven patients with RA (23 with active disease at baseline and 24 in remission) and 51 healthy subjects were evaluated during a one-year follow-up with assessments of disease activity (DAS-28) and 1H NMR spectroscopy of plasma samples. Discriminant analysis provided evidence that the metabolic profiles predicted disease severity. Cholesterol, lactate, acetylated glycoprotein, and lipid signatures were found to be candidate biomarkers for disease severity. The results also supported the link between RA and coronary artery disease. Repeated assessment using mixed linear models showed that the predictors obtained from metabolic profiles of plasma at baseline from patients with active RA were significantly different from those of patients in remission (P = 0.0007). However, after 31 days of optimized therapy, the two patient groups were not significantly different (P = 0.91). The metabolic profiles of both groups of RA patients were different from the healthy subjects. 1H NMR-based metabolic phenotyping of plasma samples in patients with RA is well suited for discovery of biomarkers and may be a potential approach for disease monitoring and personalized medication for RA therapy.

    AB - 1H NMR spectroscopy-based metabolic phenotyping was used to identify biomarkers in the plasma of patients with rheumatoid arthritis (RA). Forty-seven patients with RA (23 with active disease at baseline and 24 in remission) and 51 healthy subjects were evaluated during a one-year follow-up with assessments of disease activity (DAS-28) and 1H NMR spectroscopy of plasma samples. Discriminant analysis provided evidence that the metabolic profiles predicted disease severity. Cholesterol, lactate, acetylated glycoprotein, and lipid signatures were found to be candidate biomarkers for disease severity. The results also supported the link between RA and coronary artery disease. Repeated assessment using mixed linear models showed that the predictors obtained from metabolic profiles of plasma at baseline from patients with active RA were significantly different from those of patients in remission (P = 0.0007). However, after 31 days of optimized therapy, the two patient groups were not significantly different (P = 0.91). The metabolic profiles of both groups of RA patients were different from the healthy subjects. 1H NMR-based metabolic phenotyping of plasma samples in patients with RA is well suited for discovery of biomarkers and may be a potential approach for disease monitoring and personalized medication for RA therapy.

    KW - chemometrics

    KW - disease monitoring

    KW - metabonomics

    KW - NMR

    KW - personalized medicine

    KW - phenotyping

    KW - rheumatoid arthritis

    UR - http://www.scopus.com/inward/record.url?scp=77956334335&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77956334335&partnerID=8YFLogxK

    U2 - 10.1021/pr1002774

    DO - 10.1021/pr1002774

    M3 - Article

    C2 - 20701312

    AN - SCOPUS:77956334335

    VL - 9

    SP - 4545

    EP - 4553

    JO - Journal of Proteome Research

    JF - Journal of Proteome Research

    SN - 1535-3893

    IS - 9

    ER -